Jason Mellad - precision immunology

Jason Mellad, co-founder and CEO of OtoImmune, discusses his vision for leveraging personalised, precision immunology to better understand immune and autoimmune conditions. The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics. https://www.bioinformaticscro.com/